These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12653682)

  • 41. Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.
    Ooi EM; Watts GF; Barrett PH; Chan DC; Clifton PM; Ji J; Nestel PJ
    Asia Pac J Clin Nutr; 2007; 16(4):624-31. PubMed ID: 18042521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased particle size of triacylglycerol-enriched remnant lipoproteins, but not their plasma concentration or lipid content, augments risk prediction of incident type 2 diabetes.
    Carvalho LSF; Benseñor IM; Nogueira ACC; Duncan BB; Schmidt MI; Blaha MJ; Toth PP; Jones SR; Santos RD; Lotufo PA; Sposito AC;
    Diabetologia; 2021 Feb; 64(2):385-396. PubMed ID: 33159534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistance exercise but not aerobic exercise lowers remnant-like lipoprotein particle cholesterol in type 2 diabetes: a randomized controlled trial.
    Gavin C; Sigal RJ; Cousins M; Menard ML; Atkinson M; Khandwala F; Kenny GP; Proctor S; Ooi TC;
    Atherosclerosis; 2010 Dec; 213(2):552-7. PubMed ID: 20870234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects.
    Cohn JS; Tremblay M; Amiot M; Bouthillier D; Roy M; Genest J; Davignon J
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):149-59. PubMed ID: 8548416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristic comparison of triglyceride-rich remnant lipoprotein measurement between a new homogenous assay (RemL-C) and a conventional immunoseparation method (RLP-C).
    Yoshida H; Kurosawa H; Hirowatari Y; Ogura Y; Ikewaki K; Abe I; Saikawa S; Domitsu K; Ito K; Yanai H; Tada N
    Lipids Health Dis; 2008 May; 7():18. PubMed ID: 18485227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.
    Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ
    Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
    Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
    Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test.
    Redgrave TG; Watts GF; Martins IJ; Barrett PH; Mamo JC; Dimmitt SB; Marais AD
    J Lipid Res; 2001 May; 42(5):710-5. PubMed ID: 11352977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism.
    Shirakawa T; Nakajima K; Shimomura Y; Kobayashi J; Stanhope K; Havel P; Machida T; Sumino H; Murakami M
    Clin Chim Acta; 2015 Feb; 440():193-200. PubMed ID: 25239670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The close relationship between postprandial remnant metabolism and insulin resistance.
    Funada J; Sekiya M; Otani T; Watanabe K; Sato M; Akutsu H
    Atherosclerosis; 2004 Jan; 172(1):151-4. PubMed ID: 14709369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis.
    Weingärtner O; Weingärtner N; Scheller B; Lütjohann D; Gräber S; Schäfers HJ; Böhm M; Laufs U
    Coron Artery Dis; 2009 Sep; 20(6):376-82. PubMed ID: 19620855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
    Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High plasma level of remnant-like particle cholesterol in the metabolic syndrome.
    Satoh A; Adachi H; Tsuruta M; Hirai Y; Hiratsuka A; Enomoto M; Furuki K; Hino A; Takeuchi T; Imaizumi T
    Diabetes Care; 2005 Oct; 28(10):2514-8. PubMed ID: 16186289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measurement of serum remnant-like lipoprotein particle-triglyceride (RLP-TG) and RLP-TG/total TG ratio using highly sensitive triglyceride assay reagent.
    Nakano T; Tokita Y; Nagamine T; Tanaka A; Okazaki M; Yatsuzuka S; Tamei N; Shimomura Y; Ando Y; Akamatsu S; Fujita MQ; Nakajima K
    Clin Chim Acta; 2011 Jan; 412(1-2):71-8. PubMed ID: 20951691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relation between charge-based apolipoprotein B-containing lipoprotein subfractions and remnant-like particle cholesterol levels.
    Zhang B; Böttcher A; Imaizumi S; Noda K; Schmitz G; Saku K
    Atherosclerosis; 2007 Mar; 191(1):153-61. PubMed ID: 16620837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases.
    Nakajima K; Nakajima Y; Takeichi S; Fujita MQ
    Atherosclerosis; 2008 May; 198(1):237-46. PubMed ID: 17977545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment.
    Chan DC; Wong AT; Yamashita S; Watts GF
    Atherosclerosis; 2012 Apr; 221(2):484-9. PubMed ID: 22341868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins.
    Ishigami M; Yamashita S; Sakai N; Hirano K; Hiraoka H; Nakamura T; Matsuzawa Y
    Atherosclerosis; 2003 Jun; 168(2):359-66. PubMed ID: 12801620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.